Upload
aric-huang
View
214
Download
0
Embed Size (px)
Citation preview
8/4/2019 Cardiovascular Disorder (1)
1/59
Cardiovascular Disorder (1)
8/4/2019 Cardiovascular Disorder (1)
2/59
http://images.google.com/imgres?imgurl=http://www.plantcon.dk/img/car.jpg&imgrefurl=http://www.plantcon.dk/uk/freedown.htm&h=249&w=397&sz=9&tbnid=FIcjRkb0tV8J:&tbnh=75&tbnw=119&start=16&prev=/images%3Fq%3Dcar%26hl%3Den%26lr%3D%26ie%3DUTF-8%26sa%3DG8/4/2019 Cardiovascular Disorder (1)
3/59
Outlines
ArteriosclerosisHypertension
SyncopeShockHeart Failure
Cor Pulmonale
8/4/2019 Cardiovascular Disorder (1)
4/59
Arteriosclerosis; Atherosclerosis
Definition:Subintimal thickening of medium andlarge arteries
Pathology and pathogenesisfatty streak is evolved into fibrousplaque
fibrous plaque - smooth m. cells,connective tissues, intra and extra-cellular lipids
8/4/2019 Cardiovascular Disorder (1)
5/59
8/4/2019 Cardiovascular Disorder (1)
6/59
Cardiovascular risk factorsRiskFactors of Atherosclerosis
A. modified:DyslipidemiasHypertensionDiabetes MellitusCigarette SmokingObesity (BMI>30)Physical inactivity
Chobanian AV et al. The 7th Report of the Joint National Committee on Prevention, Detection,Evaluaation, and Treatment of High Blood Pressure. JAMA 2003:289:2560
8/4/2019 Cardiovascular Disorder (1)
7/59
B. unmodified:Age: >55 for men, >65 for womenMale gender
Increased risk in menIncreased risk in women aftermenopause
Family history of prematurecardiovascular diseaseMen
8/4/2019 Cardiovascular Disorder (1)
8/59
Risk Factors of Atherosclerosis
Risk factors (emerging)HomocystinemiaClamydial pneumonia infection
8/4/2019 Cardiovascular Disorder (1)
9/59
Atherosclerosis
Symptoms/ SignsPatients are asymptomatic untilcomplications developComplications: critical stenosis, thrombosis,aneurysm, embolism)
In brain: TIA, strokeIn heart: angina pectoris, M.I.In low extremities: intermittent claudication
DiagnosisObstruction can be confirmed by Dopplerultrasonography
Doppler ultrasonography : a tech which monitorsthe moving substance eg. flowing blood, beatingheart
8/4/2019 Cardiovascular Disorder (1)
10/59
Atherosclerosis
Prevention: prevent risk factorsTreatment
directed at its complicationsshould be aggressive for patientswith established atherosclerosis
8/4/2019 Cardiovascular Disorder (1)
11/59
*Treatment
Lifestyle changes (diet, smoking, physical activity)Diet:
Less saturated fatNo trans fatsMore fruits and vegetablesMore fiberModerate (if any) alcohol
Regular physical activity (eg, 30 to 45 min of walking,running, swimming, or cycling 3 to 5 times/wk)
Drug treatment of diagnosed risk factorsAntiplatelet drugsPossibly statins, ACE inhibitors, -blockers
8/4/2019 Cardiovascular Disorder (1)
12/59
Hypertension
8/4/2019 Cardiovascular Disorder (1)
13/59
*Hypertension-Epidemiology
In the US, about 65 million people havehypertension.Only about 70% of these people are
aware that they have hypertension, only59% are being treated, and only 34%have adequately controlled BP.In adults, hypertension occurs more
often in blacks (32%) than in whites(23%) or Mexican Americans (23%), andmorbidity and mortality are greater inblacks.
8/4/2019 Cardiovascular Disorder (1)
14/59
Systemic Hypertension
DefinitionHypertension: chronic elevation of BP:> 140/90 mmHg(Isolated) Systolic Hypertension:
systolic BP> 160, diastolic BP< 90
8/4/2019 Cardiovascular Disorder (1)
15/59
Classification Systolicpressure
Diastolicpressure
Normal
8/4/2019 Cardiovascular Disorder (1)
16/59
Hypertension Physiology:
Physiologic determinants ofarterial pressure:( BP= CO x TPR)
cardiac output (C.O.)total peripheral resistance (TPR):viscosity, radius of artery, hemotocrit
arterial blood volumeelasticity of aorta (compliance)
8/4/2019 Cardiovascular Disorder (1)
17/59
Hemodynamics of bloodpressure
Sympathetic hyperactivityesp. in youngTachycardia & increased CO
Renin - Angiotensin-Aldosteronesystem (RAS system) PG I2( prostaglandin) & TX A2( thromboxan): vasodilatation &vasoconstriction
8/4/2019 Cardiovascular Disorder (1)
18/59
8/4/2019 Cardiovascular Disorder (1)
19/59
Pathology
The target organs of hypertension:Heart:
LVH,CAD
Brain:cerebrovascular disease, hypertensiveencephalopathy
Eye (retina):arteriosclerosis, exudates, hemorrhage,papilladema
Kidney:renal arteriosclerosis, renal function impairment
8/4/2019 Cardiovascular Disorder (1)
20/59
*Etiology & ClassificationPrimary Hypertension (EssentialHypertension):
85 to 95% of cases Unknown etiology*Between ages 25-55 yearsHeredity is a predisposing factor
Environmental factors (eg, dietary Na,
obesity, stress) seem to affect onlygenetically susceptible people.
Multiple factors are probably involvedin sustaining elevated BP
8/4/2019 Cardiovascular Disorder (1)
21/59
Secondary HypertensionRenal Artery StenosisCoarctation of AortaPheochromocytoma: catecholamine-producing tumorHyperaldosteronism: tumor or
hyperplasia in zona glomerulosaOther Causes: oral contraceptiveusage, Cushings syndrome
8/4/2019 Cardiovascular Disorder (1)
22/59
8/4/2019 Cardiovascular Disorder (1)
23/59
Coarctation of Aorta
Aortic coarctation causes low bloodpressure and low blood flow in thearteries that branch off below the
narrow spot; high blood pressure occurs in the arteries that branch offcloser to the heart. As a result, aorticcoarctation often leads to high bloodpressure in the upper body and arms(or one arm) and low blood pressurein the lower body and legs.
http://www.nlm.nih.gov/medlineplus/ency/article/003083.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003083.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003082.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003082.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003083.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003083.htm8/4/2019 Cardiovascular Disorder (1)
24/59
Symptoms/ Signs
Primary hypertension:Asymptomatic until complications intarget organs
Severe hypertensionDizziness, flushed face, headache,fatigue, nervousness, blurred vision
A h h i i h
8/4/2019 Cardiovascular Disorder (1)
25/59
Approach to the patient withhypertension
HistoryPhysical Examination: leg & armBPLaboratory work-up:
BUN, Cr, CXR, renin, aldosterone
Primary hypertension: repeatedlyelevated BPExclude secondary hypertension
8/4/2019 Cardiovascular Disorder (1)
26/59
Treatment-Lifestyle modification
8/4/2019 Cardiovascular Disorder (1)
27/59
8/4/2019 Cardiovascular Disorder (1)
28/59
Treatment-Drugs
Antihypertensive drug therapy:systolic BP remains > 140 mm Hgor diastolic BP remains > 90 mmHg after 6 mo of lifestylemodifications, antihypertensivedrugs are required.
See attachment
8/4/2019 Cardiovascular Disorder (1)
29/59
*Malignant hypertension
Severe hypertension with signs of damage to target organs (primarily the brain, cardiovascular system, and kidneys).Diastolic pressure>120mm-HgAssociated with encephalopathy or nephropathy withpapilledemaClinical manifestations
BP is elevated, often markedly (diastolic > 120 mm Hg).CNS symptoms include rapidly changing neurologic
abnormalities (eg, confusion, transient cortical blindness,hemiparesis, hemisensory defects, seizures).Cardiovascular symptoms include chest pain and dyspnea.Renal involvement may be asymptomatic, although severeazotemia due to advanced renal failure may producelethargy or nausea.
8/4/2019 Cardiovascular Disorder (1)
30/59
*Malignant hypertension
Diagnosis is by BP measurement, ECG,urinalysis, and serum BUN and creatinine measurements.Treatment is immediate BP reduction
with IV drugs (eg, nitroprusside, - blockers, hydralazine). Hypertensive emergencies, requiring
aggressive and immediate treatment.Damage is rapidly progressive and often fatal.
8/4/2019 Cardiovascular Disorder (1)
31/59
*Malignant hypertension
Diastolic pressure>120mm-HgAssociated with encephalopathy ornephropathy with papilledema
Clinical manifestationsEncephalopathy:headache, seizure,
Retinopathyvisual disturbance
Deteriorating renal functionCardiac decomposition:
CHF, angina
8/4/2019 Cardiovascular Disorder (1)
32/59
8/4/2019 Cardiovascular Disorder (1)
33/59
Syncope (Fainting)
Definition:transient loss of consciousness dueto reduced cerebral blood flow
8/4/2019 Cardiovascular Disorder (1)
34/59
Causes of SyncopeI. Disorders of vascular tone orblood volume
1.Vasovagal (vasodepressor)syncope
Excessive vagal tonePrecipitated by unpleasant physical oremotional stimuliPreceded by vagal activity: nausea,yawning, visual blurring, weakness,sweatingOccur in upright; e.g. fainting to needling
8/4/2019 Cardiovascular Disorder (1)
35/59
I. Disorders of vascular tone orblood volume (cont.)
2.Postural (orthostatic) hypotensionCaused by hypovolemic or venous poolingOccurs while standing up suddenly
E.g. UGI bleeding, ectopic pregnancy rupture
E.g. after prolonged bed rest or severe varicosevein
E.g. standing without moving in healthy person
3.Carotid sinus hypersensitivityRubbing carotid sinus, causing elevated BP incarotid sinus, resulting in reduced HR & slow AVconduction
8/4/2019 Cardiovascular Disorder (1)
36/59
8/4/2019 Cardiovascular Disorder (1)
37/59
Approach to the patient withsyncope
History:the position of patient at time ofsyncope, in particular situation
Laboratory findings:blood sugar, ECG, echocardiogram,hematocrit
8/4/2019 Cardiovascular Disorder (1)
38/59
Treatment
Postural hypotension & vasovagalsyncope: horizontal postureTreat underlying causes:
Vasovagal syncope: avoid situationOrthostatic hypotension: rise slowlyVolume depletion:Bradyarrhythmia: pacemaker
8/4/2019 Cardiovascular Disorder (1)
39/59
Prognosis
Depends on causes
8/4/2019 Cardiovascular Disorder (1)
40/59
ShockDefinition:a state of inadequate blood flow orperfusion of peripheral tissues tosustain life
Resulting from:Inadequate C.O. or misdistribution ofperipheral blood flow , associatedwith hypotension and oliguria
8/4/2019 Cardiovascular Disorder (1)
41/59
Classification of shockHypovolemic shock:
HemorrhageVolume depletionInternal sequestration: the blood fromsystemic circulation to a non-functional area
Cardiogenic shock:
MyopathicArrhythmic
8/4/2019 Cardiovascular Disorder (1)
42/59
Classification of shock (cont.)
Extracardiac obstructive shock:Pericardial tamponadeTension pneumothorax
Vasodilatory shock: relativelyinadequate intravascular volume(vasodilation)
SepsisAnaphylaxis ( systemic vasodilatation)
8/4/2019 Cardiovascular Disorder (1)
43/59
8/4/2019 Cardiovascular Disorder (1)
44/59
Symptoms/ Signs of Shock
Mentation:letharge, confusion, somnolence
Hands & feet: cold, moist, cyanotic, pale
Pulse: weak, rapid ( unless terminalbradycardia)Breathing: tachypnea, hyperventilation( apnea in terminal )B.P.:
8/4/2019 Cardiovascular Disorder (1)
45/59
Hyperdynamic syndrome
A cluster of S/S which signals theonset of septic shock ( early stageof septic shock)Characterized by shaking chills,rapid rise in temperature, flushingof skin, gallop pulse, alternatingrise & fall B.P.
8/4/2019 Cardiovascular Disorder (1)
46/59
Treatment of ShockFirst Aid:
Keep warm, leg raisedStop hemorrhage
Supportive treatmentDopamine or norepinephrine
O2Carefully monitorTreat underlying causes:
Hypovolemic shock: restore intravascular
volumeVasodilatory shock: fluid resuscitation withnormal saline, vasopressor drugs,antibioticsCardiogenic shock: improving cardiacperformance
8/4/2019 Cardiovascular Disorder (1)
47/59
Prognosis of Shock
Depending on the causeUntreated shock: fatalCardiogenic shock due to M.I.,septic shock: high mortality
8/4/2019 Cardiovascular Disorder (1)
48/59
8/4/2019 Cardiovascular Disorder (1)
49/59
The Heart
www.youtube.com/watch?v=D3ZDJgFDdk0&feature=related
http://www.youtube.com/watch?v=D3ZDJgFDdk0&feature=relatedhttp://www.youtube.com/watch?v=D3ZDJgFDdk0&feature=relatedhttp://www.youtube.com/watch?v=D3ZDJgFDdk0&feature=relatedhttp://www.youtube.com/watch?v=D3ZDJgFDdk0&feature=related8/4/2019 Cardiovascular Disorder (1)
50/59
Congestive Heart Failure
Definition:a condition that the heart is unable to pumpsufficient blood for metabolizing tissues
The heart is unable to perform its functionPhysiology
Preload: end-diastolic volume ( venous return)Afterload: the load to resist ventricularcontraction
l
8/4/2019 Cardiovascular Disorder (1)
51/59
Heart Failure-Prevalence
Both the incidence and prevalence of heartfailure increase with the ageIncidence:
Over 65 years, incidence is 11/1,000 men peryear and 5/1,000 women per year
Prevalence:Over 65 years, prevalence is 40/1,000 men and30/1,000 women
( Cowie MR et al. The epidemioology of heart failure. Eur Heart J 1997;18:208-225)
Classification and Etiology of
8/4/2019 Cardiovascular Disorder (1)
52/59
Classification and Etiology ofCongestive Failure
Left ventricularfailure
Coronary arterydiseaseHypertensionCardiomyopathyCongenital heartdisease
Right ventricularfailure
Prior LV failure:pulmonary vein pr.,
pulmonary ahypertensionVolume overload: eg.over-transfusion,polycythemia
F i l Cl ifi i f H
8/4/2019 Cardiovascular Disorder (1)
53/59
Functional Classification of HeartDisease
Class INo limitation of physical activity. Ordinary physicalactivity does not cause undue fatigue, dyspnea, oranginal pain
Class II:Slight limitation of physical activity. Ordinary physicalactivity results in symptoms
Class IIIMarked limitation of physical activity. Comfortable at rest,but less than ordinary activity causes symptoms
Class IVUnable to engage in any physical activity withoutdiscomfort. Symptoms may be present even at rest
New York Heart Association
S / Si
8/4/2019 Cardiovascular Disorder (1)
54/59
Symptoms/ Signsof Congestive Heart Failure
LV failure:Fatigue on exertionDyspnea
Intolerance to coldPulmonary rales
RV failure:
Fullness in neck (jugular veindistention)Hepatomegaly,Peripheral edema
8/4/2019 Cardiovascular Disorder (1)
55/59
Acute pulmonary edema
Life threateningAcute LV failure acute pulmonaryv. hypertensionS/S:
extreme dyspneadeep cyanosistachypnea
8/4/2019 Cardiovascular Disorder (1)
56/59
Laboratory findings
EKG: LV hypertrophy, QRS wavedeeper & tallerCXR: cardiomegalyEchocardiography
T f C i H
8/4/2019 Cardiovascular Disorder (1)
57/59
Treatment of Congestive HeartFailure
1.Decrease cardiac workload:decrease physical activity
2.Control excess fluid retention:Dietary Na restrictionDiuretics
Other medicationsVasodilatorsDigoxinACE inhibitors
Refractory HF: heart transplantation
8/4/2019 Cardiovascular Disorder (1)
58/59
Symptom relief: diuretics, nitrates,digoxinLong-term management, improvedsurvival:
ACE inhibitors, -blockers, aldosteronereceptor blockers, angiotensin II receptor
blockers (ARBs)
8/4/2019 Cardiovascular Disorder (1)
59/59